Publication | Closed Access

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Medicinal ChemistryDrug TargetHealth SciencesMedicineN-dithiobenzyl PiperazinePharmacological AgentLimited ToxicityPharmacotherapyAnti-cancer AgentDrug DevelopmentLow ResistancePharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryDrug Resistance